Economic Costs of Diabetes in the U.S. in 2017

American Diabetes Association

doi:10.2337/dci18-0007

Cited by 2,528Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and ResearchHealthcare Policy and Management

Economic Costs of Diabetes in the U.S. in 2017

Open access

American Diabetes Association·2018·Diabetes Care

DOI 10.2337/dci18-0007PMC PMC5911784

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: This study updates previous estimates of the economic burden of diagnosed diabetes and quantifies the increased health resource use and lost productivity associated with diabetes in 2017. RESEARCH DESIGN AND METHODS: We use a prevalence-based approach that combines the demographics of the U.S. population in 2017 with diabetes prevalence, epidemiological data, health care cost, and economic data into a Cost of Diabetes Model. Health resource use and associated medical costs are analyzed by age, sex, race/ethnicity, insurance coverage, medical condition, and health service category. Data sources include national surveys, Medicare standard analytical files, and one of the largest claims databases for the commercially insured population in the U.S. RESULTS: The total estimated cost of diagnosed diabetes in 2017 is $327 billion, including $237 billion in direct medical costs and $90 billion in reduced productivity. For the cost categories analyzed, care for people with diagnosed diabetes accounts for 1 in 4 health care dollars in the U.S., and more than half of that expenditure is directly attributable to diabetes. People with diagnosed diabetes incur average medical expenditures of ∼$16,750 per year, of which ∼$9,600 is attributed to diabetes. People with diagnosed diabetes, on average, have medical expenditures ∼2.3 times higher than what expenditures would be in the absence of diabetes. Indirect costs include increased absenteeism ($3.3 billion) and reduced productivity while at work ($26.9 billion) for the employed population, reduced productivity for those not in the labor force ($2.3 billion), inability to work because of disease-related disability ($37.5 billion), and lost productivity due to 277,000 premature deaths attributed to diabetes ($19.9 billion). CONCLUSIONS: After adjusting for inflation, economic costs of diabetes increased by 26% from 2012 to 2017 due to the increased prevalence of diabetes and the increased cost per person with diabetes. The growth in diabetes prevalence and medical costs is primarily among the population aged 65 years and older, contributing to a growing economic cost to the Medicare program. The estimates in this article highlight the substantial financial burden that diabetes imposes on society, in addition to intangible costs from pain and suffering, resources from care provided by nonpaid caregivers, and costs associated with undiagnosed diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dci18-0007

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The difference in cost as a reason for discontinuation between the USA and UK could be attributed to direct out-of-pocket costs for individuals in the USA compared with costs being covered by the National Health Service in the UK.
“Cost was highlighted as a reason for discontinuation by 16% of US respondents, compared with only 4% of UK respondents, which could be attributed to the direct out-of-pocket costs for individuals in the USA [19] compared with costs being covered by the National Health Service in the UK [20].”
From Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK (2020) · cites this paper as [19]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Association between Water Intake, Chronic Kidney Disease, and Cardiovascular Disease: A Cross-Sectional Analysis of NHANES Data
Sontrop, J. M., Dixon, S. N., Garg, A. X., Jiménez, I. B., Dohein, O., Huang, S. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,903 · see citing works
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,159 · see citing works
Self-citation
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323 · see citing works
Self-citation
Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence
Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309 · see citing works
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure
Okura, Y., Urban, L. H., Mahoney, D. W., Jacobsen, S. J., & Rodeheffer, R. J. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.04.005 · Cited by 1,237 · see citing works
A review of adjusted estimators of attributable risk
Bénichou, J. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000303 · Cited by 440 · see citing works
Health and Productivity as a Business Strategy: A Multiemployer Study
Loeppke, R., Taitel, M. S., Haufle, V., Parry, T., Kessler, R. C., & Jinnett, K. (2009) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181a39180 · Cited by 352 · see citing works
Burden of Diabetes on the Ability to Work
Breton, M.-C., Guénette, L., Amiche, M. A., Kayibanda, J. F., Grégoire, J., & Moisan, J. (2013) · Diabetes Care · doi:10.2337/dc12-0354 · Cited by 188 · see citing works
Absenteeism and Employer Costs Associated With Chronic Diseases and Health Risk Factors in the US Workforce
Asay, G. R. B., Roy, K., Lang, J. E., Payne, R. L., & Howard, D. H. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.150503 · Cited by 117 · see citing works
Prevalence of Diabetes and the Burden of Comorbid Conditions Among Elderly Nursing Home Residents
Dybicz, S. B., Thompson, S., Molotsky, S., & Stuart, B. (2011) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.05.001 · Cited by 91 · see citing works
Impact of Obesity on Work Productivity and Role Disability in Individuals with and at Risk for Diabetes Mellitus
Rodbard, H., Fox, K., & Grandy, S. (2009) · American Journal of Health Promotion · doi:10.4278/ajhp.081010-quan-243 · Cited by 84 · see citing works
The Relationship Between Patient-Reported Tolerability Issues With Oral Antidiabetic Agents and Work Productivity Among Patients Having Type 2 Diabetes
DiBonaventura, M., Link, C. R., Pollack, M. F., Wagner, J.-S., & Williams, S. A. (2011) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e318209e0ce · Cited by 21 · see citing works

Flagged first, then by citations

Sorted by citations

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175 · see citing works
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036 · see citing works
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · see citing works
Social determinants of health and diabetes: A scientific review
Hill-Briggs, F., Adler, N. E., Berkowitz, S. A., Chin, M. H., Gary-Webb, T. L., Navas-Acien, A., Thornton, P. L., & Haire-Joshu, D. (2021) · Diabetes Care · doi:10.2337/dci20-0053 · Cited by 1,732 · see citing works
Circadian clocks and insulin resistance
Stenvers, D. J., Scheer, F. A. J. L., Schrauwen, P., la Fleur, S. E., & Kalsbeek, A. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0122-1 · Cited by 733 · see citing works
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545 · see citing works
Diabetes Self-management Education and Support in Adults With Type 2 Diabetes: A Consensus Report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association
Powers, M. A., Bardsley, J. K., Cypress, M., Funnell, M. M., Harms, D., Hess-Fischl, A., Hooks, B., Isaacs, D., Mandel, E. D., Maryniuk, M. D., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0023 · Cited by 500 · see citing works
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s010 · Cited by 487 · see citing works
Self-citation
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Das, S. R., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s010 · Cited by 465 · see citing works
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Januzzi, J. L., Kalyani, R. R., Kosiborod, M., Magwire, M., Morris, P. B., Neumiller, J. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.037 · Cited by 466 · see citing works
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s010 · Cited by 471 · see citing works
Self-citation
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351 · see citing works
Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
Yun, J.-S., & Ko, S.-H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154838 · Cited by 292 · see citing works
American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288 · see citing works
Mediterranean diet nutrients to turn the tide against insulin resistance and related diseases
Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272 · see citing works
Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes
The GRADE Study Research Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200433 · Cited by 222 · see citing works
Health care-related economic burden of polycystic ovary syndrome in the United States: pregnancy-related and long-term health consequences
Riestenberg, C., Jagasia, A., Markovic, D., Buyalos, R. P., & Azziz, R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab613 · Cited by 210 · see citing works
“Food Is Medicine” Strategies for Nutrition Security and Cardiometabolic Health Equity
Mozaffarian, D., Aspry, K. E., Garfield, K., Kris-Etherton, P., Seligman, H., Velarde, G. P., Williams, K., & Yang, E. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.023 · Cited by 219 · see citing works
The cost of diabetes care-an elephant in the room
Riddle, M. C., & Herman, W. H. (2018) · Diabetes Care · doi:10.2337/dci18-0012 · Cited by 191 · see citing works
Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation
Perraudeau, F., McMurdie, P., Bullard, J., Cheng, A., Cutcliffe, C., Deo, A., Eid, J., Gines, J., Iyer, M., Justice, N., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001319 · Cited by 186 · see citing works
Reach and use of diabetes prevention services in the United States, 2016-2017.
Ali, M. K., McKeever Bullard, K., Imperatore, G., Benoit, S. R., Rolka, D. B., Albright, A. L., & Gregg, E. W. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3160 · Cited by 153 · see citing works
Glycemia reduction in type 2 diabetes–microvascular and cardiovascular outcomes
The GRADE Study Research Group (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2200436 · Cited by 159 · see citing works
Burden and management of type 2 diabetes in rural United States
Dugani, S. B., Mielke, M. M., & Vella, A. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3410 · Cited by 151 · see citing works
Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: The glucose telemetry system, a randomized clinical trial
Singh, L. G., Satyarengga, M., Marcano, I., Scott, W. H., Pinault, L. F., Feng, Z., Sorkin, J. D., Umpierrez, G. E., & Spanakis, E. K. (2020) · Diabetes Care · doi:10.2337/dc20-0840 · Cited by 154 · see citing works
The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review
Bessonova, L., Ogden, K., Doane, M. J., O'Sullivan, A. K., & Tohen, M. (2020) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s259338 · Cited by 147 · see citing works
Effects of SGLT2 inhibitors and GLP-1 receptor agonists on renin-angiotensin-aldosterone system
Puglisi, S., Rossini, A., Poli, R., Dughera, F., Pia, A., Terzolo, M., & Reimondo, G. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.738848 · Cited by 143 · see citing works
1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2021
Association, A. D. (2021) · Diabetes Care · doi:10.2337/dc21-s001 · Cited by 124 · see citing works
Self-citation
Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study
McCoy, R. G., Dykhoff, H. J., Sangaralingham, L., Ross, J. S., Karaca-Mandic, P., Montori, V. M., & Shah, N. D. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0213 · Cited by 122 · see citing works
The Next Generation of Diabetes Translation: A Path to Health Equity
Haire-Joshu, D., & Hill-Briggs, F. (2019) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040218-044158 · Cited by 116 · see citing works
Mobile delivery of the Diabetes Prevention Program in people with prediabetes: randomized controlled trial.
Toro-Ramos, T., Michaelides, A., Anton, M., Karim, Z., Kang-Oh, L., Argyrou, C., Loukaidou, E., Charitou, M. M., Sze, W., & Miller, J. D. (2020) · JMIR mHealth and uHealth · doi:10.2196/17842 · Cited by 107 · see citing works
Optimal Dose and Type of Physical Activity to Improve Glycemic Control in People Diagnosed With Type 2 Diabetes: A Systematic Review and Meta-analysis
Gallardo-Gómez, D., Salazar-Martínez, E., Alfonso-Rosa, R. M., Ramos-Munell, J., del Pozo-Cruz, J., del Pozo Cruz, B., & Álvarez-Barbosa, F. (2024) · Diabetes Care · doi:10.2337/dc23-0800 · Cited by 111 · see citing works
Burden and consequences of financial hardship from medical bills among nonelderly adults with diabetes mellitus in the United States.
Caraballo, C., Valero-Elizondo, J., Khera, R., Mahajan, S., Grandhi, G. R., Virani, S. S., Mszar, R., Krumholz, H. M., & Nasir, K. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006139 · Cited by 104 · see citing works
Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis
Powell, R. E., Zaccardi, F., Beebe, C., Chen, X. M., Crawford, A., Cuddeback, J., Gabbay, R. A., Kissela, L., Litchman, M. L., Mehta, R., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14455 · Cited by 99 · see citing works
Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease
Patorno, E., Htoo, P. T., Glynn, R. J., Schneeweiss, S., Wexler, D. J., Pawar, A., Bessette, L. G., Chin, K., Everett, B. M., & Kim, S. C. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0893 · Cited by 103 · see citing works
The association between sustained HbA1c control and long-term complications among individuals with type 2 diabetes: a retrospective study
Boye, K. S., Thieu, V. T., Lage, M. J., Miller, H., & Paczkowski, R. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02106-4 · Cited by 99 · see citing works
Digital health application integrating wearable data and behavioral patterns improves metabolic health
Zahedani, A. D., McLaughlin, T., Veluvali, A., Aghaeepour, N., Hosseinian, A., Agarwal, S., Ruan, J., Tripathi, S., Woodward, M., Hashemi, N., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00956-y · Cited by 96 · see citing works
The Future of Islet Transplantation Is Now
Bottino, R., Knoll, M. F., Knoll, C. A., Bertera, S., & Trucco, M. M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00202 · Cited by 93 · see citing works
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
and the DPP Research Group, Nathan, D. M., Bennett, P. H., Crandall, J. P., Edelstein, S. L., Goldberg, R. B., Kahn, S. E., Knowler, W. C., Mather, K. J., Mudaliar, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4928-8 · Cited by 91 · see citing works
First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: A Cost-Effectiveness Study
Choi, J. G., Winn, A. N., Skandari, M. R., Franco, M. I., Staab, E. M., Alexander, J., Wan, W., Zhu, M., Huang, E. S., Philipson, L., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m21-2941 · Cited by 87 · see citing works
A virtual type 2 diabetes clinic using continuous glucose monitoring and endocrinology visits
Dixon, R. F., Zisser, H., Layne, J. E., Barleen, N. A., Miller, D. P., Moloney, D. P., Majithia, A. R., Gabbay, R. A., & Riff, J. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819888662 · Cited by 80 · see citing works
Quantifying the Sex‐Race/Ethnicity‐Specific Burden of Obesity on Incident Diabetes Mellitus in the United States, 2001 to 2016: MESA and NHANES
Cameron, N. A., Petito, L. C., McCabe, M., Allen, N. B., O’Brien, M. J., Carnethon, M. R., & Khan, S. S. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018799 · Cited by 76 · see citing works
Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts
DiCorpo, D., LeClair, J., Cole, J. B., Sarnowski, C., Ahmadizar, F., Bielak, L. F., Blokstra, A., Bottinger, E. P., Chaker, L., Chen, Y.-D. I., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1395 · Cited by 66 · see citing works
Dietary interventions to treat type 2 diabetes in adults with a goal of remission: an expert consensus statement from the American College of Lifestyle Medicine
Rosenfeld, R. M., Kelly, J. H., Agarwal, M., Aspry, K., Barnett, T., Davis, B. C., Fields, D., Gaillard, T., Gulati, M., Guthrie, G. E., et al. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276221087624 · Cited by 71 · see citing works
Reviewing U.S. connected diabetes care: the newest member of the team
Levine, B. J., Close, K. L., & Gabbay, R. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0273 · Cited by 66 · see citing works
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study
Rajamand Ekberg, N., Bodholdt, U., Catarig, A.-M., Catrina, S.-B., Grau, K., Holmberg, C. N., Klanger, B., & Knudsen, S. T. (2021) · Primary Care Diabetes · doi:10.1016/j.pcd.2021.06.008 · Cited by 63 · see citing works
Mobile Health Intervention in Patients With Type 2 Diabetes: A Randomized Clinical Trial
Gerber, B. S., Biggers, A., Tilton, J. J., Smith Marsh, D. E., Lane, R., Mihailescu, D., Lee, J., & Sharp, L. K. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.33629 · Cited by 61 · see citing works
Program ACTIVE II: Outcomes from a randomized, multistate community-based depression treatment for rural and urban adults with type 2 diabetes
de Groot, M., Shubrook, J. H., Hornsby, W. G., Pillay, Y., Mather, K. J., Fitzpatrick, K., Yang, Z., & Saha, C. (2019) · Diabetes Care · doi:10.2337/dc18-2400 · Cited by 56 · see citing works
Prevalence of Glycemic Control and Factors Associated With Poor Glycemic Control: A Systematic Review and Meta-analysis
Bitew, Z. W., Alemu, A., Jember, D. A., Tadesse, E., Getaneh, F. B., Seid, A., & Weldeyonnes, M. (2023) · INQUIRY: The Journal of Health Care Organization, Provision, and Financing · doi:10.1177/00469580231155716 · Cited by 58 · see citing works
Reduced medical spending associated with increased use of a remote diabetes management program and lower mean blood glucose values
Whaley, C. M., Bollyky, J. B., Lu, W., Painter, S., Schneider, J., Zhao, Z., He, X., Johnson, J., & Meadows, E. S. (2019) · Journal of Medical Economics · doi:10.1080/13696998.2019.1609483 · Cited by 49 · see citing works
Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities
McCoy, R. G., Van Houten, H. K., Karaca-Mandic, P., Ross, J. S., Montori, V. M., & Shah, N. D. (2021) · Diabetes Care · doi:10.2337/dc20-2977 · Cited by 57 · see citing works
Primary Care Providers’ Prediabetes Screening, Testing, and Referral Behaviors
Nhim, K., Khan, T., Gruss, S. M., Wozniak, G., Kirley, K., Schumacher, P., Luman, E. T., & Albright, A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.017 · Cited by 54 · see citing works
Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home
Azelton, K. R., Crowley, A. P., Vence, N., Underwood, K., Morris, G., Kelly, J., & Landry, M. J. (2021) · Frontiers in Digital Health · doi:10.3389/fdgth.2021.764735 · Cited by 49 · see citing works
Self-Efficacy and Diabetes Self-Management in Middle-Aged and Older Adults in the United States: A Systematic Review
Qin, W., Blanchette, J. E., & Yoon, M. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0051 · Cited by 51 · see citing works
Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme
Xin, Y., Davies, A., Briggs, A., McCombie, L., Messow, C. M., Grieve, E., Leslie, W. S., Taylor, R., & Lean, M. E. J. (2020) · Diabetologia · doi:10.1007/s00125-020-05224-2 · Cited by 52 · see citing works
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus
Gouda, M., Matsukawa, M., & Iijima, H. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s176749 · Cited by 46 · see citing works
Diabetes education impact on hypoglycemia outcomes: a systematic review of evidence and gaps in the literature
LaManna, J., Litchman, M. L., Dickinson, J. K., Todd, A., Julius, M. M., Whitehouse, C. R., Hyer, S., & Kavookjian, J. (2019) · The Diabetes Educator · doi:10.1177/0145721719855931 · Cited by 50 · see citing works
The financial impact of an inpatient diabetes management service
Haque, W. Z., Demidowich, A. P., Sidhaye, A., Golden, S. H., & Zilbermint, M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-020-01374-0 · Cited by 48 · see citing works
Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review
Xie, Z., Hu, J., Gu, H., Li, M., & Chen, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1244432 · Cited by 47 · see citing works
Concentrated insulins: Clinical update of therapeutic options
Umpierrez, G. E., Holt, E. H., Einhorn, D., & McGill, J. B. (2020) · Endocrine Practice · doi:10.4158/ep-2019-0607 · Cited by 44 · see citing works
Six Digital Health Technologies That Will Transform Diabetes
Klonoff, A. N., Lee, W.-A. (., Xu, N. Y., Nguyen, K. T., DuBord, A., & Kerr, D. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211043498 · Cited by 44 · see citing works
Predicting and preventing acute care re-utilization by patients with diabetes
Rubin, D. J., & Shah, A. A. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01402-7 · Cited by 44 · see citing works
Weight loss in a digital app-based diabetes prevention program powered by artificial intelligence.
Graham, S. A., Pitter, V., Hori, J. H., Stein, N., & Branch, O. H. (2022) · DIGITAL HEALTH · doi:10.1177/20552076221130619 · Cited by 43 · see citing works
Can risk be predicted? An umbrella systematic review of current risk prediction models for cardiovascular diseases, diabetes and hypertension
Lucaroni, F., Cicciarella Modica, D., Macino, M., Palombi, L., Abbondanzieri, A., Agosti, G., Biondi, G., Morciano, L., & Vinci, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030234 · Cited by 42 · see citing works
The Internet Knows More Than My Physician: Qualitative Interview Study of People With Rare Diseases and How They Use Online Support Groups
Ashtari, S., & Taylor, A. D. (2022) · Journal of Medical Internet Research · doi:10.2196/39172 · Cited by 41 · see citing works
Literature Review of Type 2 Diabetes Management and Health Literacy
Alsaedi, R., & McKeirnan, K. (2021) · Diabetes Spectrum · doi:10.2337/ds21-0014 · Cited by 38 · see citing works
A systematic review of cost-effectiveness of sodium-glucose cotransporter inhibitors for type 2 diabetes.
Yoshida, Y., Cheng, X., Shao, H., Fonseca, V. A., & Shi, L. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1292-5 · Cited by 39 · see citing works
Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK
Roborel de Climens, A., Pain, E., Boss, A., & Shaunik, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00843-9 · Cited by 38 · see citing works
National trends in pediatric admissions for diabetic ketoacidosis, 2006–2016
Everett, E. M., Copeland, T. P., Moin, T., & Wisk, L. E. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab287 · Cited by 38 · see citing works
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-plus weight-management programme to achieve remission of type 2 diabetes
Xin, Y., Davies, A., McCombie, L., Briggs, A., Messow, C.-M., Grieve, E., Leslie, W. S., Taylor, R., & Lean, M. E. J. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30346-2 · Cited by 32 · see citing works
Comparison of the effectiveness of lifestyle modification with other treatments on the incidence of type 2 diabetes in people at high risk: A network meta-analysis
Yamaoka, K., Nemoto, A., & Tango, T. (2019) · Nutrients · doi:10.3390/nu11061373 · Cited by 32 · see citing works
How Are Income and Education Related to the Prevention and Management of Diabetes?
Allen, K., & McFarland, M. (2020) · Journal of Aging and Health · doi:10.1177/0898264319879608 · Cited by 33 · see citing works
2018 Health Care & Education Presidential Address: The American Diabetes Association in the Era of Health Care Transformation
Hill-Briggs, F. (2019) · Diabetes Care · doi:10.2337/dci18-0051 · Cited by 30 · see citing works
The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes
Boye, K. S., Ford, J. H., Thieu, V. T., Lage, M. J., & Terrell, K. A. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01384-7 · Cited by 26 · see citing works
Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the <scp>United States</scp>
Valentine, W. J., Hoog, M., Mody, R., Belger, M., & Pollock, R. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14979 · Cited by 28 · see citing works
A tailored cognitive-behavioural intervention produces comparable reductions in regimen-related distress in adults with type 2 diabetes regardless of insulin use: 12-month outcomes from the COMRADE trial
Lutes, L. D., Cummings, D. M., Littlewood, K., Le, M. T., Kirian, K., Patil, S., Solar, C., Carraway, M., & Hambidge, B. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.05.016 · Cited by 22 · see citing works
Physical activity and diabetes mortality in people with type 2 diabetes: a prospective cohort study of 0.5 million US people
Beltran-Valls, M. R., Cabanas-Sánchez, V., Sadarangani, K. P., Rodríguez-Artalejo, F., Moliner-Urdiales, D., & Martínez-Gómez, D. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101410 · Cited by 21 · see citing works
Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial
Reed, J., Dong, T., Eaton, E., Friswold, J., Porges, J., Al‐Kindi, S. G., Rajagopalan, S., & Neeland, I. J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15608 · Cited by 22 · see citing works
Effect of Mobile Apps on Medication Adherence of Type 2 Diabetes Mellitus: A Systematic Review of Recent Studies
Hakami, A. M., Almutairi, B., Alanazi, A. S., & Alzahrani, M. A. (2024) · Cureus · doi:10.7759/cureus.51791 · Cited by 20 · see citing works
Examining the evidence for weight management in individuals with type 2 diabetes
Garvey, W. T., Umpierrez, G. E., Dunn, J. P., Kwan, A. Y. M., Varnado, O. J., Konig, M., & Levine, J. A. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14764 · Cited by 18 · see citing works
Evaluation of high-deductible health plans and acute glycemic complications among adults with diabetes
Jiang, D. H., Herrin, J., Van Houten, H. K., & McCoy, R. G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.50602 · Cited by 17 · see citing works
The Impact of Physical Activity in Patients With Type 2 Diabetes
Bassin, S. R., & Srinath, R. (2025) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231180541 · Cited by 17 · see citing works
Trends in Lifestyle Counseling for Adults With and Without Diabetes in the U.S., 2005–2015
Shah, M. K., Moore, M. A., Narayan, K. M. V., & Ali, M. K. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.07.005 · Cited by 17 · see citing works
Dietary self-management using mobile health technology for adults with type 2 diabetes: a scoping review
Zheng, Y., Campbell Rice, B., Melkus, G. D., Sun, M., Zweig, S., Jia, W., Parekh, N., He, H., Zhang, Y., & Wylie-Rosett, J. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231174038 · Cited by 17 · see citing works
Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients
Mosenzon, O., Miller, E. M., & Warren, M. L. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1800286 · Cited by 16 · see citing works
A 12-month follow-up of the effects of a digital diabetes prevention program (VP transform for prediabetes) on weight and physical activity among adults with prediabetes: secondary analysis.
Batten, R., Alwashmi, M. F., Mugford, G., Nuccio, M., Besner, A., & Gao, Z. (2022) · JMIR Diabetes · doi:10.2196/23243 · Cited by 16 · see citing works
Instituting a successful discharge plan for patients with type 2 diabetes: challenges and solutions
Demidowich, A. P., Batty, K., & Zilbermint, M. (2022) · Diabetes Spectrum · doi:10.2337/dsi22-0013 · Cited by 15 · see citing works
Impact of glucagon-like peptide 1 agonist deprescription in type 2 diabetes in a real-world setting: a propensity score matched cohort study
McKenzie, A. L., & Athinarayanan, S. J. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01547-0 · Cited by 14 · see citing works
Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States
Bajpai, S., Wong-Jacobson, S., Liu, D., Mitchell, B., Haynes, G., Syring, K., Ali, A. K., & Chinthammit, C. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.3.385 · Cited by 14 · see citing works
Uptake and use of a diabetes management program with a mobile glucometer
Garabedian, L. F., Ross-Degnan, D., LeCates, R. F., & Wharam, J. F. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.03.010 · Cited by 13 · see citing works
Cost-effectiveness of three doses of a behavioral intervention to prevent or delay type 2 diabetes in rural areas
Radcliff, T. A., Côté, M. J., Whittington, M. D., Daniels, M. J., Bobroff, L. B., Janicke, D. M., & Perri, M. G. (2020) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2019.10.025 · Cited by 11 · see citing works
Inpatient hyperglycemia and transitions of care: A systematic review
Lansang, M. C., Zhou, K., & Korytkowski, M. T. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.01.016 · Cited by 9 · see citing works
Patient understanding of discharge instructions for home diabetes self-management and risk for hospital readmission and emergency department visits
Pinkhasova, D., Swami, J. B., Patel, N., Karslioglu-French, E., Hlasnik, D. S., Delisi, K. J., Donihi, A. C., Rubin, D. J., Siminerio, L. S., Wang, L., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.03.013 · Cited by 9 · see citing works
Equity and AI Governance at Academic Medical Centers
(2024) · The American Journal of Managed Care · doi:10.37765/ajmc.2024.89555 · Cited by 8 · see citing works
Immediate and Long-Term Effects of an 8-Week Digital Mental Health Intervention on Adults With Poorly Managed Type 2 Diabetes: Protocol for a Randomized Controlled Trial
Boucher, E., Moskowitz, J. T., Kackloudis, G. M., Stafford, J. L., Kwok, I., & Parks, A. C. (2020) · JMIR Research Protocols · doi:10.2196/18578 · Cited by 6 · see citing works
Evaluating the Implementation of a Digital Diabetes Prevention Program in an Integrated Health Care Delivery System Among Older Adults: Results of a Natural Experiment
Fitzpatrick, S. L., Mayhew, M., Rawlings, A. M., Smith, N., Nyongesa, D. B., Vollmer, W. M., Stevens, V. J., Grall, S. K., & Fortmann, S. P. (2022) · Clinical Diabetes · doi:10.2337/cd21-0114 · Cited by 5 · see citing works
Does the encounter type matter when defining diabetes complications in electronic health records?
Hong, D., Shen, Y., Monnette, A., Liu, S., Shao, H., Nauman, E., Price-Haywood, E., Hu, G., & Shi, L. (2020) · Medical Care · doi:10.1097/mlr.0000000000001297 · Cited by 4 · see citing works
Continuous Glucose Monitors Among Adults With Type 2 Diabetes Mellitus in the Primary Care Setting: Qualitative Study Informed by Technology Acceptance Model and Health Belief Model
Knopp, M. I., Castleman, A. M., Schwarz, A., Belger-Wallace, J., Falciglia, M., Zuzek, A., & Mendonca, E. (2025) · JMIR Diabetes · doi:10.2196/73446 · Cited by 2 · see citing works
Machine learning-driven risk prediction for post-hospitalization diabetes case management: Integrating clinical and social determinants of health
Lee, S.-Y., Saleem, M., Land, A. M., DeLaney, E. W., Garretson, A. R., Patel, M., Hall, A. G., Westrick, S., Ovalle, F., Cherrington, A. L., et al. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106604

Authors: American Diabetes Association
Corresponding author: American Diabetes Association
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2018-03-22
Volume: 41
Issue: 5
Pages: 917-928
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dci18-0007
PMC: PMC5911784
OpenAlex: W3092065440
Cited by: 2,528
References: 12
Citations by year: 2026: 72 · 2025: 178 · 2024: 304 · 2023: 425 · 2022: 402 · 2021: 380 · 2020: 376 · 2019: 274 · 2018: 89 · 2017: 4 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 11
FWCI: 425.69
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.diabetesjournals.org/content/license (vor, 29 d)
Locations: Diabetes Care (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
Keywords: diabetes mellitus, economic burden of disease, health care costs, productivity loss, absenteeism, disability, premature mortality, Medicare, diabetes prevalence, economic burden, older adults
MeSH terms: Adult, Aged, Aged, 80 and over, Diabetes Mellitus, Health Expenditures, Female, Health Resources, Humans, Male, Middle Aged, United States, Prevalence, Health Care Costs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Economic Costs of Diabetes in the U.S. in 2017

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks